eHealth Inc. has announced its financial results for the second quarter of 2025. The company reported total revenue of $60.8 million, a decrease of 8% compared to the same quarter in the previous year, but still exceeding internal expectations. The decline in revenue was primarily attributed to a drop in Medicare approved members due to changes in regulations affecting dual-eligible beneficiaries, partially mitigated by an increase in positive net adjustment revenue or tail revenue. The Medicare segment experienced a 2% year-over-year decline in revenue, totaling $58.1 million, due to a reduction in Medicare submissions. Despite this, the segment's gross profit increased by 26% to $19.1 million. eHealth's total operating costs and expenses decreased by 11% to $83.8 million, down from $93.8 million in Q2 2024. This was mainly due to a significant reduction in Medicare segment variable marketing and advertising spend. The company reported a GAAP net loss of $17.4 million, an improvement of $10.6 million compared to the net loss of $28.0 million in the same period the previous year. Additionally, the adjusted EBITDA was $(14.1) million, compared to $(15.5) million in Q2 2024. As of June 30, 2025, eHealth held $105.2 million in cash, cash equivalents, and marketable securities, reflecting robust cash collections from new Medicare enrollments. The company has begun preparations for the upcoming Medicare Annual Enrollment Period, emphasizing the importance of customer loyalty and the growing contribution from its direct branded channels.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.